Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03104699
Title Phase 1 / 2 Study of AGEN2034 in Advanced Tumors and Cervical Cancer
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Agenus Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | POL | FRA | EST | ESP | BRA | BEL | AUS


No variant requirements are available.